| References |
Top |
| REF 1 |
Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem. 2003 May 2;278(18):16021-9.
|
| REF 2 |
Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J Biol Chem. 2002 Nov 22;277(47):45028-33.
|
| REF 3 |
AP2alpha alters the transcriptional activity and stability of p53. Oncogene. 2006 Apr 6;25(15):2148-59.
|
| REF 4 |
Modulation of IFN- receptor 1 expression by AP-2 influences IFN- sensitivity of cancer cells. Am J Pathol. 2012 Feb;180(2):661-71.
|
| REF 5 |
Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells. Circ Res. 2005 Mar 18;96(5):518-25.
|
| REF 6 |
Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation. EMBO Rep. 2007 Apr;8(4):394-400.
|
| REF 7 |
Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. Mol Cancer Res. 2008 Dec;6(12):1881-93.
|
| REF 8 |
Ubiquitin-interacting motifs of Epsin are involved in the regulation of insulin-dependent endocytosis. J Biochem. 2005 Mar;137(3):355-64.
|
| REF 9 |
Epsin 1 is a polyubiquitin-selective clathrin-associated sorting protein. Traffic. 2006 Mar;7(3):262-81.
|
